Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Øystein Flesland

75 publications found

Original articles

Mulac A, Elvik S, Flesland Ø (2024)
Lack of clarity about 'patient safety incidents'
Tidsskr Nor Laegeforen, 144 (5)
DOI 10.4045/tidsskr.24.0053, PubMed 38651714

Espinosa A, Steinsvåg CT, Flesland Ø (2024)
Haemolytic transfusion reactions caused by non-ABO red cell antibodies reported to the Norwegian Haemovigilance System 2004-2020
Vox Sang (in press)
DOI 10.1111/vox.13605, PubMed 38373854

Nissen-Meyer LSH, Steinsvåg TT, Fenstad MH, Sørvoll IH, Hvalryg M, Titze TL, Magnussen K, Kristoffersen G, Johnsen KMN, Llohn AH, Hermundstad B, Høiback LS, Haugen M, Kristoffersen EK, Boulland LML, Kran AB, Lund-Johansen F, Vaage JT, Flesland Ø, Hervig TA (2023)
Convalescent plasma from Norwegian blood donors to treat COVID-19
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.22.0180, PubMed 37589362

Buchta C, Coucke W, Huf W, Griesmacher A, Müller MM, Mayr WR, Flesland Ø, Politis C, Wiersum-Osselton J, Aburto A, Badrick T, Bouacida L, Budina M, Duenas JA, Geilenkeuser WJ, Guimarães AVP, Hecimovic A, Jutzi M, Lee CK, Lim YA, Mammen J, Molnár PM, Mokhtari A, Morabito G, Muñiz-Diaz E et al. (2022)
External quality assessment providers' services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions
Clin Chem Lab Med, 60 (3), 361-369
DOI 10.1515/cclm-2021-1219, PubMed 35041777

Deilkas ET, Haugen M, Risberg MB, Narbuvold H, Flesland O, Nylen U, Rutberg H (2021)
Longitudinal rates of hospital adverse events that contributed to death in Norway and Sweden from 2013 to 2018
J. Patient Saf. Risk Manag., 26 (4), 153-160
DOI 10.1177/25160435211026125

Steinsvåg TT, Dimoski T, Solheim BG, Flesland Ø (2018)
[Transfusion practice at Sørlandet Hospital]
Tidsskr Nor Laegeforen, 138 (16)
DOI 10.4045/tidsskr.17.1057, PubMed 30344330

Steinsvåg CT, Espinosa A, Flesland Ø (2013)
Eight years with haemovigilance in Norway. What have we learnt?
Transfus Apher Sci, 49 (3), 548-52
DOI 10.1016/j.transci.2013.09.013, PubMed 24157220

Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK et al. (2011)
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009
Vox Sang, 102 (1), 82-90
DOI 10.1111/j.1423-0410.2011.01506.x, PubMed 21933190

Reesink HW, Panzer S, Gonzalez CA, Lena N, Muntaabski P, Gimbatti S, Wood E, Lambermont M, Deneys V, Sondag D, Alport T, Towns D, Devine D, Turek P, Auvinen MK, Koski T, Lin CK, Lee CK, Tsoi WC, Lawlor E, Grazzini G, Piccinini V, Catalano L, Pupella S, Kato H et al. (2010)
Haemovigilance for the optimal use of blood products in the hospital
Vox Sang, 99 (3), 278-93
DOI 10.1111/j.1423-0410.2010.01323.x, PubMed 20345518

Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
[Syphilis and blood transfusion]
Tidsskr Nor Laegeforen, 130 (8), 839-41
DOI 10.4045/tidsskr.08.0188, PubMed 20418930

Bettelheim D, Panzer S, Reesink HW, Csapo B, Pessoa C, Guerra F, Wendel S, Calda P, Sprogøe U, Dziegiel M, Aitokallio-Tallberg A, Koskinen S, Kuosmanen M, Legler TJ, Stein W, Villa S, Villa MA, Trespidi L, Acaia B, Vandenbussche FP, Brand A, de Haas M, Kanhai HH, Gounder D, Flanagan P et al. (2010)
Monitoring and treatment of anti-D in pregnancy
Vox Sang, 99 (2), 177-92
DOI 10.1111/j.1423-0410.2010.01322.x, PubMed 20331536

Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland Ø, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S (2010)
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria
Vox Sang, 98 (3 Pt 2), 468-78
DOI 10.1111/j.1423-0410.2009.01301.x, PubMed 20136789

Reesink HW, Panzer S, Dettke M, Gabriel C, Lambermont M, Deneys V, Sondag D, Dickmeiss E, Fischer-Nielsen A, Korhonen M, Krusius T, Ali A, Tiberghien P, Schrezenmeier H, Tonn T, Seifried E, Klüter H, Politis C, Stavropoulou-Gioka A, Parara M, Flesland O, Nascimento F, Balint B, Marin P, Bart T et al. (2009)
New cellular therapies: is there a role for transfusion services?
Vox Sang, 97 (1), 77-90
DOI 10.1111/j.1423-0410.2009.01184.x, PubMed 19392779

Solheim BG, Chetty R, Flesland O (2008)
Indications for use and cost-effectiveness of pathogen-reduced ABO-universal plasma
Curr Opin Hematol, 15 (6), 612-7
DOI 10.1097/MOH.0b013e32831366d3, PubMed 18832933

Reesink HW, Engelfriet CP, Hyland CA, Coghlan P, Tait B, Wsolak M, Keller AJ, Henn G, Mayr WR, Thomas I, Osselaer JC, Lambermont M, Beaten M, Wendel S, Qiu Y, Georgsen J, Krusius T, Mäki T, Andreu G, Morel P, Lefrère JJ, Rebulla P, Giovanelli S, Butti B, Lecchi L et al. (2008)
Biobanks of blood from donors and recipients of blood products
Vox Sang, 94 (3), 242-260
DOI 10.1111/j.1423-0410.2007.01020.x, PubMed 18225990

Flesland O, Seghatchian J (2007)
Commentary on the 5th annual course in Transfusion Medicine arranged by the Norwegian Red Cross Blood Programme
Transfus Apher Sci, 36 (3), 321-3
DOI 10.1016/j.transci.2007.01.009, PubMed 17572154

Flesland O (2007)
A comparison of complication rates based on published haemovigilance data
Intensive Care Med, 33 Suppl 1, S17-21
DOI 10.1007/s00134-007-2875-1, PubMed 17676435

Wendel S, Biagini S, Trigo F, Fontão-Wendel R, Taaning E, Jørgensen J, Riisom K, Krusius T, Koskinen S, Kretschmer V, Karger R, Lawlor E, Okazaki H, Charlewood R, Brand A, Solheim BG, Flesland O, Letowska M, Zupanska B, Muñiz-Diaz E, Nogués N, Senn M, Mansouri-Taleghani B, Chapman CE, Massey E et al. (2007)
Measures to prevent TRALI
Vox Sang, 92 (3), 258-77
DOI 10.1111/j.1423-0410.2006.00870.x, PubMed 17348877

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
DOI 10.1080/00365510601045088, PubMed 17454845

Engelfriet CP, Reesink HW, Fontão-Wendel R, Lazar A, Cardoso RA, Olyntho S, Achkar R, Wendel S, Pisacka M, Taaning E, Koski T, Matilainen J, Kretschmer V, Karger R, Politis C, Katsea P, Malamou V, Aprili G, Piccoli P, Gandini G, Franchini M, Schonewille H, Brand A, Solheim BG, Flesland O et al. (2006)
Prevention and diagnosis of delayed haemolytic transfusion reactions
Vox Sang, 91 (4), 353-68
DOI 10.1111/j.1423-0410.2006.00812_1.x, PubMed 17105616

Flesland O, Seghatchian J (2006)
Transfusion medicine in Norway: new problems and new opportunities
Transfus Apher Sci, 35 (2), 93-5
DOI 10.1016/j.transci.2006.03.002, PubMed 17030150

Jenum PA, Søberg P, Maal HB, Flesland Ø (2005)
[Overutilization of clinical biochemical analyses?]
Tidsskr Nor Laegeforen, 125 (18), 2509-11
PubMed 16186875

Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S et al. (2005)
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003
Vox Sang, 88 (4), 289-303
DOI 10.1111/j.1423-0410.2005.00636_1.x, PubMed 15877653

Espinosa A, Steinsvåg CT, Flesland O (2005)
Hemovigilance in Norway
Transfus Apher Sci, 32 (1), 17-9
DOI 10.1016/j.transci.2004.06.010, PubMed 15737868

Flesland O, Leivestad T, Solheim BG (2005)
Survival of renal allografts from living donors and the importance of being the mother of the organ donor
Transfus Apher Sci, 32 (1), 13-5
DOI 10.1016/j.transci.2004.06.009, PubMed 15737867

Flesland O, Seghatchian J (2005)
Current issues in transfusion medicine in Norway
Transfus Apher Sci, 32 (1), 7-10
DOI 10.1016/j.transci.2004.06.007, PubMed 15737866

Solheim BG, Flesland O, Seghatchian J, Brosstad F (2004)
Clinical implications of red blood cell and platelet storage lesions: an overview
Transfus Apher Sci, 31 (3), 185-9
DOI 10.1016/j.transci.2004.09.004, PubMed 15556465

Flesland O, Ip LS, Storlien AS, Spurkland A, Larsen J, Solheim BG (2004)
Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates
Transfus Apher Sci, 31 (3), 173-80
DOI 10.1016/j.transci.2004.07.012, PubMed 15556463

Hervig T, Flesland O, Svenningsen V, Bosnes V (2004)
Guidelines for transfusion in Norway
Transfus Apher Sci, 31 (3), 181-4
DOI 10.1016/j.transci.2004.09.003, PubMed 15556464

Flesland O, Eskelund AK, Flesland AB, Falch D, Solheim BG, Seghatchian J (2004)
Transferrin receptor in serum. A new tool in the diagnosis and prevention of iron deficiency in blood donors
Transfus Apher Sci, 31 (1), 11-6
DOI 10.1016/j.transci.2004.01.011, PubMed 15294189

Solheim BG, Flesland O, Brosstad F, Mollnes TE, Seghatchian J (2003)
Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
Transfus Apher Sci, 29 (2), 133-9
DOI 10.1016/S1473-0502(03)00117-4, PubMed 12941351

Flesland O, Pfeffer PF, Solheim BG, Mellbye OJ (2003)
Donor lymphocytes transferred with the graft to kidney recipients. Potential for establishing microchimerism
Transfus Apher Sci, 28 (2), 125-8
DOI 10.1016/S1473-0502(03)00013-2, PubMed 12679115

Flesland Ø (2002)
[Reverse apheresis--semiautomatic erythrocyte transfusion]
Tidsskr Nor Laegeforen, 122 (6), 621
PubMed 11998716

Flesland O, Solheim BG, Seghatchian J (2001)
Transfusion medicine in Norway 2001. Time for change
Transfus Apher Sci, 25 (3), 211-4
DOI 10.1016/s1473-0502(01)00129-x, PubMed 11846147

Flesland Ø, Solheim BG (2001)
[How much is enough?]
Tidsskr Nor Laegeforen, 121 (20), 2421
PubMed 11603055

Flesland Ø, Bengtsson A (2001)
[Can patients treated with therapeutic bloodletting become blood donors?]
Tidsskr Nor Laegeforen, 121 (12), 1493-4
PubMed 11449773

Flesland O (1998)
Perspective on Nordic views on selective/universal leukodepletion
Transfus Sci, 19 (4), 355-7
DOI 10.1016/s0955-3886(98)00065-4, PubMed 10351154

RATKJE SK, FLESLAND O (1995)
MODELING THE FREEZE CONCENTRATION PROCESS BY IRREVERSIBLE THERMODYNAMICS
J. Food Eng., 25 (4), 553-567
DOI 10.1016/0260-8774(94)00034-7

Flesland O (1995)
Freeze concentration by layer crystallization
Dry. Technol., 13 (8-9), 1713-1739
DOI 10.1080/07373939508917048

Flesland O, Song X, Strommen I (1994)
Freeze concentration of some heat sensitive solutions
DEVELOPMENTS IN FOOD ENGINEERING, PTS 1 AND 2: PROCEEDINGS OF THE 6TH INTERNATIONAL CONGRESS ON ENGINEERING AND FOOD, 385-387

Sudmann E, Vik H, Rait M, Todnem K, Andersen KJ, Julsham K, Flesland O, Rungby J (1994)
Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement
Med Prog Technol, 20 (3-4), 179-84
PubMed 7877562

Nordøy I, Schrumpf E, Elgjo K, Flesland O, Andersen Glende J, Orjasaeter H, Siebke JC (1994)
Liver disease in anti-hepatitis C virus-positive Norwegian blood donors
Scand J Gastroenterol, 29 (1), 77-81
DOI 10.3109/00365529409090441, PubMed 8128181

Borch-Iohnsen B, Halvorsen R, Stenberg V, Flesland O, Mowinckel P (1993)
The effect of daily low-dose iron supplements in female blood donors with depleted iron stores: comparison with female non-donors
Scand J Clin Lab Invest, 53 (8), 789-91
DOI 10.3109/00365519309086490, PubMed 8140388

Flesland O, Solheim BG, Bergan A (1993)
Red cell antibody production due to primary immune response by lymphoid tissue in a grafted liver
Transpl Immunol, 1 (1), 86-7
DOI 10.1016/0966-3274(93)90065-g, PubMed 8081767

Flesland O, Solheim BG (1992)
[Quality control of leukocyte filtration of blood products]
Tidsskr Nor Laegeforen, 112 (24), 3090-1
PubMed 1471084

Flesland O (1992)
[Ferritin concentration in serum in health adults. Significance for blood donation]
Tidsskr Nor Laegeforen, 112 (15), 1950-1
PubMed 1509453

Flesland O, Botten G, Solheim BG, Orjasaeter H (1992)
[Attitude of blood donors towards cholesterol measurement]
Tidsskr Nor Laegeforen, 112 (13), 1710-2
PubMed 1509430

Flesland O, Botten G, Solheim BG, Orjasaeter H (1992)
[Changes in serum cholesterol level in blood donors over a 2-year period]
Tidsskr Nor Laegeforen, 112 (7), 890-2
PubMed 1557757

Flesland O, Halvorsen R, Solheim BG, Orjasaeter H (1991)
[The effect of conversion from blood donation to plasma donation on serum ferritin and hemoglobin]
Tidsskr Nor Laegeforen, 111 (2), 189-90
PubMed 1998176

Halvorsen R, Flesland O (1990)
[Pregnancy and iron storage]
Tidsskr Nor Laegeforen, 110 (25), 3222-4
PubMed 2256033

Flesland O, Solheim BG, Mellbye OJ, Vandvik B, Albrechtsen DA (1990)
Quantitation of immunoglobulins produced by donor lymphocytes in transplant patients and the possible identification of donor cell-produced antiviral antibodies by imprint immunofixation
Scand J Immunol, 32 (2), 149-52
DOI 10.1111/j.1365-3083.1990.tb02904.x, PubMed 2202044

Flesland O, Halvorsen R, Solheim BG, Glende JA, Orjasaeter H (1990)
[Cholesterol status of blood donors. Motivation for dietary changes and their effects]
Tidsskr Nor Laegeforen, 110 (17), 2226-9
PubMed 2375012

Flesland O, Halvorsen R, Solheim BG, Orjasaeter H (1990)
[The effect of plasmapheresis on IgG and albumin]
Tidsskr Nor Laegeforen, 110 (15), 1936-7
PubMed 2363163

Albrechtsen D, Geiran O, Foerster A, Fauchald P, Flesland O, Lindberg H, Solheim BG, Vartdal F, Frøysaker T (1990)
Cardiac transplantation from a blood group ABO-incompatible donor: a case report
Transplant Proc, 22 (1), 143
PubMed 2309290

Halvorsen R, Flesland O, Solheim BG, Borch-Iohnsen B, Leivestad T (1990)
[Iron status in blood donors evaluated by serum ferritin]
Tidsskr Nor Laegeforen, 110 (2), 189-91
PubMed 2300954

Flesland O, Solheim BG (1989)
[Cytomegalovirus. Presence of antibodies in married couples]
Tidsskr Nor Laegeforen, 109 (9), 957-8
PubMed 2539658

Flesland O, Pitkänen J (1987)
[Infections in burn injuries. Clinical findings, colonization and treatment]
Tidsskr Nor Laegeforen, 107 (5), 464-6
PubMed 3576532

Steier JA, Akslen LA, Flesland O, Askvik K (1987)
Fetal heart block, anti-SSA and anti-SSB antibodies. Association with intra-uterine growth retardation, fetal death and lupus anticoagulant
Acta Obstet Gynecol Scand, 66 (8), 737-9
DOI 10.3109/00016348709004156, PubMed 3129899

Review articles

Wood EM, Ang AL, Bisht A, Bolton-Maggs PH, Bokhorst AG, Flesland O, Land K, Wiersum-Osselton JC, Schipperus MR, Tiberghien P, Whitaker BI (2019)
International haemovigilance: what have we learned and what do we need to do next?
Transfus Med, 29 (4), 221-230
DOI 10.1111/tme.12582, PubMed 30729612